NFKB1 and cardiac hypertrophy: The role of SIRT6 in cardiac hypertrophy has been investigated using loss‐of‐function and gain‐of‐function models and manifested to attenuate myocardial hypertrophy by inhibiting NF‐κB activation, AKT signalling pathway and so on 38, 39.